NCT03403179

Functional Remediation for Bipolar Disorder

Completed NA Last updated 28 February 2019

What this trial tests

NA trial testing Functional Remediation in Bipolar Disorder in 30 participants. Completed in 20 December 2018.

Timeline

17 November 2017

Primary endpoint
10 December 2018

20 December 2018

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	30
Start date	17 November 2017
Primary completion	10 December 2018
Estimated completion	20 December 2018
Sites	1 location across United States

Drugs / interventions tested

• Functional Remediation

Conditions studied

• Bipolar Disorder — all drugs for Bipolar Disorder →

Sponsor

University of Michigan

Who can join

Adults 18 to 55, any sex, with Bipolar Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.